Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose crossover fully replicate bioequivalence study of atorvastatin calcium tablets 80 mg under fasting conditions
TCTR20170109003Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of atorvastatin in hypercholesterolemia, combined dyslipidaemia and hyperlipidemia (2 arms), sponsored by Bio-innova. Planned start May 2017; status: not yet recruiting.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemiacombined dyslipidaemiahyperlipidemia
Beyond the preview
Go deeper on TCTR20170109003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170109003.